nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—lung cancer—colon cancer	0.381	1	CtDrD
Cisplatin—PTGS2—colon cancer	0.1	0.54	CbGaD
Cisplatin—ABCB1—colon cancer	0.0852	0.46	CbGaD
Cisplatin—ABCC5—Fluorouracil—colon cancer	0.0529	0.191	CbGbCtD
Cisplatin—ABCC3—Fluorouracil—colon cancer	0.0333	0.12	CbGbCtD
Cisplatin—ABCC3—Vincristine—colon cancer	0.0303	0.109	CbGbCtD
Cisplatin—BCHE—Irinotecan—colon cancer	0.0202	0.0731	CbGbCtD
Cisplatin—ABCC3—Methotrexate—colon cancer	0.0183	0.0663	CbGbCtD
Cisplatin—ABCC2—Irinotecan—colon cancer	0.0158	0.0569	CbGbCtD
Cisplatin—ABCG2—Irinotecan—colon cancer	0.0142	0.0514	CbGbCtD
Cisplatin—ABCC2—Vincristine—colon cancer	0.0138	0.0497	CbGbCtD
Cisplatin—ABCG2—Fluorouracil—colon cancer	0.0137	0.0494	CbGbCtD
Cisplatin—ABCG2—Vincristine—colon cancer	0.0125	0.045	CbGbCtD
Cisplatin—CYP2B6—Irinotecan—colon cancer	0.01	0.0362	CbGbCtD
Cisplatin—CYP2C9—Capecitabine—colon cancer	0.00857	0.0309	CbGbCtD
Cisplatin—ABCC2—Methotrexate—colon cancer	0.00834	0.0301	CbGbCtD
Cisplatin—MPO—superior mesenteric artery—colon cancer	0.00783	0.147	CbGeAlD
Cisplatin—ABCG2—Methotrexate—colon cancer	0.00754	0.0272	CbGbCtD
Cisplatin—ABCB1—Irinotecan—colon cancer	0.00514	0.0185	CbGbCtD
Cisplatin—CYP2C9—Fluorouracil—colon cancer	0.00508	0.0183	CbGbCtD
Cisplatin—ABCB1—Vincristine—colon cancer	0.00449	0.0162	CbGbCtD
Cisplatin—ABCB1—Methotrexate—colon cancer	0.00272	0.00982	CbGbCtD
Cisplatin—ABCC2—bile—colon cancer	0.00172	0.0324	CbGeAlD
Cisplatin—MT2A—gall bladder—colon cancer	0.00132	0.0249	CbGeAlD
Cisplatin—ATP7A—endothelium—colon cancer	0.00132	0.0248	CbGeAlD
Cisplatin—ATP7A—blood vessel—colon cancer	0.00122	0.0229	CbGeAlD
Cisplatin—GSTM1—blood vessel—colon cancer	0.00101	0.019	CbGeAlD
Cisplatin—MT1A—renal system—colon cancer	0.000761	0.0143	CbGeAlD
Cisplatin—MPO—endothelium—colon cancer	0.000707	0.0133	CbGeAlD
Cisplatin—CYP4A11—renal system—colon cancer	0.000701	0.0132	CbGeAlD
Cisplatin—NQO1—gall bladder—colon cancer	0.000668	0.0126	CbGeAlD
Cisplatin—MPO—blood vessel—colon cancer	0.000652	0.0123	CbGeAlD
Cisplatin—MT2A—renal system—colon cancer	0.000634	0.0119	CbGeAlD
Cisplatin—MT1A—digestive system—colon cancer	0.000624	0.0117	CbGeAlD
Cisplatin—GSTT1—renal system—colon cancer	0.00062	0.0117	CbGeAlD
Cisplatin—ABCC3—gall bladder—colon cancer	0.000599	0.0113	CbGeAlD
Cisplatin—GSTP1—gall bladder—colon cancer	0.000597	0.0112	CbGeAlD
Cisplatin—ATP7A—epithelium—colon cancer	0.000592	0.0111	CbGeAlD
Cisplatin—CYP4A11—digestive system—colon cancer	0.000575	0.0108	CbGeAlD
Cisplatin—ATP7A—renal system—colon cancer	0.000549	0.0103	CbGeAlD
Cisplatin—MT2A—lymphoid tissue—colon cancer	0.000526	0.0099	CbGeAlD
Cisplatin—MT2A—digestive system—colon cancer	0.00052	0.00978	CbGeAlD
Cisplatin—GSTT1—lymphoid tissue—colon cancer	0.000515	0.00969	CbGeAlD
Cisplatin—GSTT1—digestive system—colon cancer	0.000509	0.00957	CbGeAlD
Cisplatin—CYP4A11—vagina—colon cancer	0.000508	0.00955	CbGeAlD
Cisplatin—ABCC6—renal system—colon cancer	0.000504	0.00947	CbGeAlD
Cisplatin—SOD1—smooth muscle tissue—colon cancer	0.000499	0.00939	CbGeAlD
Cisplatin—ATP7B—vagina—colon cancer	0.000494	0.00929	CbGeAlD
Cisplatin—SLC31A2—bone marrow—colon cancer	0.000471	0.00886	CbGeAlD
Cisplatin—SLC31A1—renal system—colon cancer	0.000468	0.00881	CbGeAlD
Cisplatin—MT1A—liver—colon cancer	0.000465	0.00875	CbGeAlD
Cisplatin—XDH—renal system—colon cancer	0.000462	0.0087	CbGeAlD
Cisplatin—GSTM1—renal system—colon cancer	0.000457	0.0086	CbGeAlD
Cisplatin—SLC31A2—vagina—colon cancer	0.000451	0.00849	CbGeAlD
Cisplatin—CYP4A11—liver—colon cancer	0.000428	0.00806	CbGeAlD
Cisplatin—ATP7B—liver—colon cancer	0.000417	0.00784	CbGeAlD
Cisplatin—ATP7A—bone marrow—colon cancer	0.000415	0.00781	CbGeAlD
Cisplatin—ATP7A—vagina—colon cancer	0.000398	0.00748	CbGeAlD
Cisplatin—MT2A—liver—colon cancer	0.000387	0.00729	CbGeAlD
Cisplatin—SLC31A1—digestive system—colon cancer	0.000384	0.00722	CbGeAlD
Cisplatin—SLC31A2—liver—colon cancer	0.000381	0.00716	CbGeAlD
Cisplatin—GSTM1—lymphoid tissue—colon cancer	0.000379	0.00714	CbGeAlD
Cisplatin—XDH—digestive system—colon cancer	0.000379	0.00714	CbGeAlD
Cisplatin—GSTT1—liver—colon cancer	0.000379	0.00713	CbGeAlD
Cisplatin—GSTP1—embryo—colon cancer	0.000378	0.00711	CbGeAlD
Cisplatin—GSTM1—digestive system—colon cancer	0.000375	0.00705	CbGeAlD
Cisplatin—SOD1—bone marrow—colon cancer	0.000363	0.00683	CbGeAlD
Cisplatin—SLC22A2—renal system—colon cancer	0.000363	0.00682	CbGeAlD
Cisplatin—MT1A—lymph node—colon cancer	0.000357	0.00671	CbGeAlD
Cisplatin—SLC31A1—bone marrow—colon cancer	0.000354	0.00666	CbGeAlD
Cisplatin—SOD1—vagina—colon cancer	0.000348	0.00655	CbGeAlD
Cisplatin—NQO1—epithelium—colon cancer	0.000345	0.0065	CbGeAlD
Cisplatin—SLC31A1—vagina—colon cancer	0.000339	0.00638	CbGeAlD
Cisplatin—ATP7A—liver—colon cancer	0.000335	0.00631	CbGeAlD
Cisplatin—XDH—vagina—colon cancer	0.000335	0.0063	CbGeAlD
Cisplatin—NQO1—smooth muscle tissue—colon cancer	0.000333	0.00626	CbGeAlD
Cisplatin—PTGS2—endothelium—colon cancer	0.000321	0.00603	CbGeAlD
Cisplatin—NQO1—renal system—colon cancer	0.00032	0.00603	CbGeAlD
Cisplatin—ATP7B—lymph node—colon cancer	0.000319	0.00601	CbGeAlD
Cisplatin—MPO—epithelium—colon cancer	0.000317	0.00597	CbGeAlD
Cisplatin—GSTP1—epithelium—colon cancer	0.000309	0.00581	CbGeAlD
Cisplatin—ABCC6—liver—colon cancer	0.000308	0.00579	CbGeAlD
Cisplatin—GSTP1—smooth muscle tissue—colon cancer	0.000297	0.00559	CbGeAlD
Cisplatin—SLC22A2—digestive system—colon cancer	0.000297	0.00559	CbGeAlD
Cisplatin—PTGS2—blood vessel—colon cancer	0.000296	0.00556	CbGeAlD
Cisplatin—MPO—renal system—colon cancer	0.000294	0.00554	CbGeAlD
Cisplatin—SOD1—liver—colon cancer	0.000294	0.00552	CbGeAlD
Cisplatin—SLC31A2—lymph node—colon cancer	0.000292	0.00549	CbGeAlD
Cisplatin—ABCC3—renal system—colon cancer	0.000287	0.00541	CbGeAlD
Cisplatin—GSTP1—renal system—colon cancer	0.000286	0.00538	CbGeAlD
Cisplatin—SLC31A1—liver—colon cancer	0.000286	0.00538	CbGeAlD
Cisplatin—XDH—liver—colon cancer	0.000283	0.00532	CbGeAlD
Cisplatin—GSTM1—liver—colon cancer	0.000279	0.00525	CbGeAlD
Cisplatin—PTGS2—gall bladder—colon cancer	0.000278	0.00524	CbGeAlD
Cisplatin—NQO1—digestive system—colon cancer	0.000263	0.00494	CbGeAlD
Cisplatin—ABCC5—bone marrow—colon cancer	0.000259	0.00487	CbGeAlD
Cisplatin—ATP7A—lymph node—colon cancer	0.000257	0.00484	CbGeAlD
Cisplatin—ABCC5—vagina—colon cancer	0.000248	0.00466	CbGeAlD
Cisplatin—MPO—lymphoid tissue—colon cancer	0.000245	0.0046	CbGeAlD
Cisplatin—MPO—digestive system—colon cancer	0.000242	0.00454	CbGeAlD
Cisplatin—GSTP1—lymphoid tissue—colon cancer	0.000238	0.00447	CbGeAlD
Cisplatin—ABCC3—digestive system—colon cancer	0.000236	0.00444	CbGeAlD
Cisplatin—GSTP1—digestive system—colon cancer	0.000235	0.00442	CbGeAlD
Cisplatin—NQO1—vagina—colon cancer	0.000232	0.00436	CbGeAlD
Cisplatin—ABCC2—renal system—colon cancer	0.00023	0.00432	CbGeAlD
Cisplatin—SOD1—lymph node—colon cancer	0.000225	0.00423	CbGeAlD
Cisplatin—MPO—bone marrow—colon cancer	0.000223	0.00419	CbGeAlD
Cisplatin—SLC31A1—lymph node—colon cancer	0.000219	0.00413	CbGeAlD
Cisplatin—GSTP1—bone marrow—colon cancer	0.000216	0.00407	CbGeAlD
Cisplatin—GSTM1—lymph node—colon cancer	0.000214	0.00403	CbGeAlD
Cisplatin—ABCC5—liver—colon cancer	0.000209	0.00394	CbGeAlD
Cisplatin—GSTP1—vagina—colon cancer	0.000207	0.0039	CbGeAlD
Cisplatin—NQO1—liver—colon cancer	0.000196	0.00368	CbGeAlD
Cisplatin—ABCC2—digestive system—colon cancer	0.000188	0.00354	CbGeAlD
Cisplatin—ABCB1—blood vessel—colon cancer	0.000183	0.00344	CbGeAlD
Cisplatin—BCHE—smooth muscle tissue—colon cancer	0.00018	0.00339	CbGeAlD
Cisplatin—MPO—liver—colon cancer	0.00018	0.00339	CbGeAlD
Cisplatin—PTGS2—embryo—colon cancer	0.000176	0.00332	CbGeAlD
Cisplatin—Myocardial infarction—Vincristine—colon cancer	0.000176	0.00267	CcSEcCtD
Cisplatin—ABCC3—liver—colon cancer	0.000176	0.0033	CbGeAlD
Cisplatin—GSTP1—liver—colon cancer	0.000175	0.00329	CbGeAlD
Cisplatin—Stomatitis—Vincristine—colon cancer	0.000175	0.00265	CcSEcCtD
Cisplatin—Polyuria—Capecitabine—colon cancer	0.000173	0.00262	CcSEcCtD
Cisplatin—Acute coronary syndrome—Irinotecan—colon cancer	0.000172	0.00261	CcSEcCtD
Cisplatin—Renal failure—Irinotecan—colon cancer	0.000172	0.00261	CcSEcCtD
Cisplatin—Myocardial infarction—Irinotecan—colon cancer	0.000171	0.0026	CcSEcCtD
Cisplatin—Stomatitis—Irinotecan—colon cancer	0.00017	0.00258	CcSEcCtD
Cisplatin—Deafness—Capecitabine—colon cancer	0.00017	0.00257	CcSEcCtD
Cisplatin—Haemolytic anaemia—Capecitabine—colon cancer	0.000168	0.00255	CcSEcCtD
Cisplatin—Hyperuricaemia—Methotrexate—colon cancer	0.000168	0.00254	CcSEcCtD
Cisplatin—Acute coronary syndrome—Fluorouracil—colon cancer	0.000165	0.0025	CcSEcCtD
Cisplatin—Dysarthria—Methotrexate—colon cancer	0.000164	0.0025	CcSEcCtD
Cisplatin—Ulcer—Methotrexate—colon cancer	0.000164	0.0025	CcSEcCtD
Cisplatin—Renal failure acute—Capecitabine—colon cancer	0.000164	0.00249	CcSEcCtD
Cisplatin—Myocardial infarction—Fluorouracil—colon cancer	0.000164	0.00249	CcSEcCtD
Cisplatin—Neuropathy peripheral—Fluorouracil—colon cancer	0.000164	0.00249	CcSEcCtD
Cisplatin—Stomatitis—Fluorouracil—colon cancer	0.000163	0.00247	CcSEcCtD
Cisplatin—Conjunctivitis—Fluorouracil—colon cancer	0.000163	0.00247	CcSEcCtD
Cisplatin—Amnesia—Capecitabine—colon cancer	0.000161	0.00245	CcSEcCtD
Cisplatin—ABCC5—lymph node—colon cancer	0.00016	0.00302	CbGeAlD
Cisplatin—Bradycardia—Irinotecan—colon cancer	0.00016	0.00242	CcSEcCtD
Cisplatin—Urinary tract disorder—Vincristine—colon cancer	0.000159	0.00241	CcSEcCtD
Cisplatin—Blood uric acid increased—Methotrexate—colon cancer	0.000158	0.0024	CcSEcCtD
Cisplatin—Connective tissue disorder—Vincristine—colon cancer	0.000158	0.0024	CcSEcCtD
Cisplatin—Urethral disorder—Vincristine—colon cancer	0.000158	0.00239	CcSEcCtD
Cisplatin—Cerebrovascular accident—Capecitabine—colon cancer	0.000155	0.00235	CcSEcCtD
Cisplatin—CYP2B6—renal system—colon cancer	0.000155	0.00291	CbGeAlD
Cisplatin—Connective tissue disorder—Irinotecan—colon cancer	0.000154	0.00234	CcSEcCtD
Cisplatin—Hyponatraemia—Capecitabine—colon cancer	0.000152	0.00231	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.000152	0.0023	CcSEcCtD
Cisplatin—Visual impairment—Irinotecan—colon cancer	0.000151	0.00229	CcSEcCtD
Cisplatin—NQO1—lymph node—colon cancer	0.00015	0.00282	CbGeAlD
Cisplatin—Cardiac disorder—Vincristine—colon cancer	0.000149	0.00227	CcSEcCtD
Cisplatin—Skin exfoliation—Methotrexate—colon cancer	0.000149	0.00225	CcSEcCtD
Cisplatin—Face oedema—Capecitabine—colon cancer	0.000146	0.00222	CcSEcCtD
Cisplatin—Flushing—Irinotecan—colon cancer	0.000146	0.00221	CcSEcCtD
Cisplatin—Cardiac disorder—Irinotecan—colon cancer	0.000146	0.00221	CcSEcCtD
Cisplatin—Mediastinal disorder—Vincristine—colon cancer	0.000145	0.0022	CcSEcCtD
Cisplatin—Irritability—Capecitabine—colon cancer	0.000145	0.0022	CcSEcCtD
Cisplatin—PTGS2—epithelium—colon cancer	0.000144	0.00271	CbGeAlD
Cisplatin—Alopecia—Vincristine—colon cancer	0.000142	0.00216	CcSEcCtD
Cisplatin—BCHE—digestive system—colon cancer	0.000142	0.00267	CbGeAlD
Cisplatin—Blood creatinine increased—Capecitabine—colon cancer	0.000142	0.00216	CcSEcCtD
Cisplatin—Immune system disorder—Irinotecan—colon cancer	0.000142	0.00215	CcSEcCtD
Cisplatin—Mediastinal disorder—Irinotecan—colon cancer	0.000141	0.00214	CcSEcCtD
Cisplatin—Dehydration—Capecitabine—colon cancer	0.000141	0.00214	CcSEcCtD
Cisplatin—ABCC2—liver—colon cancer	0.00014	0.00264	CbGeAlD
Cisplatin—Arrhythmia—Irinotecan—colon cancer	0.00014	0.00213	CcSEcCtD
Cisplatin—PTGS2—smooth muscle tissue—colon cancer	0.000139	0.00261	CbGeAlD
Cisplatin—Alopecia—Irinotecan—colon cancer	0.000139	0.0021	CcSEcCtD
Cisplatin—Orthostatic hypotension—Capecitabine—colon cancer	0.000139	0.0021	CcSEcCtD
Cisplatin—Hypokalaemia—Capecitabine—colon cancer	0.000138	0.00209	CcSEcCtD
Cisplatin—MPO—lymph node—colon cancer	0.000138	0.0026	CbGeAlD
Cisplatin—Breast disorder—Capecitabine—colon cancer	0.000137	0.00208	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000137	0.00207	CcSEcCtD
Cisplatin—Nasopharyngitis—Capecitabine—colon cancer	0.000136	0.00206	CcSEcCtD
Cisplatin—ABCC3—lymph node—colon cancer	0.000135	0.00253	CbGeAlD
Cisplatin—Flatulence—Irinotecan—colon cancer	0.000135	0.00204	CcSEcCtD
Cisplatin—Arrhythmia—Fluorouracil—colon cancer	0.000134	0.00204	CcSEcCtD
Cisplatin—GSTP1—lymph node—colon cancer	0.000134	0.00252	CbGeAlD
Cisplatin—PTGS2—renal system—colon cancer	0.000134	0.00251	CbGeAlD
Cisplatin—Alopecia—Fluorouracil—colon cancer	0.000133	0.00201	CcSEcCtD
Cisplatin—Muscle spasms—Irinotecan—colon cancer	0.000131	0.00199	CcSEcCtD
Cisplatin—BCHE—bone marrow—colon cancer	0.000131	0.00247	CbGeAlD
Cisplatin—Erythema—Fluorouracil—colon cancer	0.000131	0.00198	CcSEcCtD
Cisplatin—Anaemia—Vincristine—colon cancer	0.00013	0.00197	CcSEcCtD
Cisplatin—Polyuria—Methotrexate—colon cancer	0.000129	0.00195	CcSEcCtD
Cisplatin—CYP2B6—lymphoid tissue—colon cancer	0.000128	0.00241	CbGeAlD
Cisplatin—Sweating increased—Capecitabine—colon cancer	0.000128	0.00194	CcSEcCtD
Cisplatin—CYP2B6—digestive system—colon cancer	0.000127	0.00238	CbGeAlD
Cisplatin—Ill-defined disorder—Irinotecan—colon cancer	0.000127	0.00192	CcSEcCtD
Cisplatin—ABCG2—bone marrow—colon cancer	0.000127	0.00238	CbGeAlD
Cisplatin—Anaemia—Irinotecan—colon cancer	0.000126	0.00191	CcSEcCtD
Cisplatin—Abdominal discomfort—Capecitabine—colon cancer	0.000126	0.00191	CcSEcCtD
Cisplatin—BCHE—vagina—colon cancer	0.000126	0.00236	CbGeAlD
Cisplatin—CYP2C9—digestive system—colon cancer	0.000126	0.00236	CbGeAlD
Cisplatin—Leukopenia—Vincristine—colon cancer	0.000125	0.0019	CcSEcCtD
Cisplatin—Pancytopenia—Capecitabine—colon cancer	0.000125	0.00189	CcSEcCtD
Cisplatin—Vision blurred—Fluorouracil—colon cancer	0.000123	0.00187	CcSEcCtD
Cisplatin—Malaise—Irinotecan—colon cancer	0.000123	0.00187	CcSEcCtD
Cisplatin—Renal failure acute—Methotrexate—colon cancer	0.000122	0.00186	CcSEcCtD
Cisplatin—Leukopenia—Irinotecan—colon cancer	0.000122	0.00185	CcSEcCtD
Cisplatin—Convulsion—Vincristine—colon cancer	0.000121	0.00184	CcSEcCtD
Cisplatin—ABCG2—vagina—colon cancer	0.000121	0.00228	CbGeAlD
Cisplatin—Anaemia—Fluorouracil—colon cancer	0.000121	0.00183	CcSEcCtD
Cisplatin—Myalgia—Vincristine—colon cancer	0.000119	0.00181	CcSEcCtD
Cisplatin—Leukopenia—Fluorouracil—colon cancer	0.000117	0.00178	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Methotrexate—colon cancer	0.000117	0.00177	CcSEcCtD
Cisplatin—Acute coronary syndrome—Capecitabine—colon cancer	0.000115	0.00175	CcSEcCtD
Cisplatin—Cerebrovascular accident—Methotrexate—colon cancer	0.000115	0.00175	CcSEcCtD
Cisplatin—Renal failure—Capecitabine—colon cancer	0.000115	0.00174	CcSEcCtD
Cisplatin—Discomfort—Irinotecan—colon cancer	0.000115	0.00174	CcSEcCtD
Cisplatin—Myocardial infarction—Capecitabine—colon cancer	0.000115	0.00174	CcSEcCtD
Cisplatin—Neuropathy peripheral—Capecitabine—colon cancer	0.000115	0.00174	CcSEcCtD
Cisplatin—Anaphylactic shock—Vincristine—colon cancer	0.000114	0.00174	CcSEcCtD
Cisplatin—Oedema—Vincristine—colon cancer	0.000114	0.00174	CcSEcCtD
Cisplatin—Stomatitis—Capecitabine—colon cancer	0.000114	0.00173	CcSEcCtD
Cisplatin—Infection—Vincristine—colon cancer	0.000114	0.00172	CcSEcCtD
Cisplatin—Conjunctivitis—Capecitabine—colon cancer	0.000114	0.00172	CcSEcCtD
Cisplatin—Convulsion—Fluorouracil—colon cancer	0.000113	0.00172	CcSEcCtD
Cisplatin—Nervous system disorder—Vincristine—colon cancer	0.000112	0.0017	CcSEcCtD
Cisplatin—Thrombocytopenia—Vincristine—colon cancer	0.000112	0.0017	CcSEcCtD
Cisplatin—CYP2B6—vagina—colon cancer	0.000112	0.00211	CbGeAlD
Cisplatin—Oedema—Irinotecan—colon cancer	0.000111	0.00169	CcSEcCtD
Cisplatin—Anaphylactic shock—Irinotecan—colon cancer	0.000111	0.00169	CcSEcCtD
Cisplatin—Myalgia—Fluorouracil—colon cancer	0.000111	0.00169	CcSEcCtD
Cisplatin—PTGS2—lymphoid tissue—colon cancer	0.000111	0.00209	CbGeAlD
Cisplatin—Infection—Irinotecan—colon cancer	0.000111	0.00168	CcSEcCtD
Cisplatin—Hyperhidrosis—Vincristine—colon cancer	0.000111	0.00168	CcSEcCtD
Cisplatin—Hepatobiliary disease—Capecitabine—colon cancer	0.000111	0.00168	CcSEcCtD
Cisplatin—Discomfort—Fluorouracil—colon cancer	0.00011	0.00167	CcSEcCtD
Cisplatin—PTGS2—digestive system—colon cancer	0.00011	0.00206	CbGeAlD
Cisplatin—Nervous system disorder—Irinotecan—colon cancer	0.000109	0.00166	CcSEcCtD
Cisplatin—ABCB1—embryo—colon cancer	0.000109	0.00205	CbGeAlD
Cisplatin—Thrombocytopenia—Irinotecan—colon cancer	0.000109	0.00165	CcSEcCtD
Cisplatin—Anorexia—Vincristine—colon cancer	0.000109	0.00165	CcSEcCtD
Cisplatin—Irritability—Methotrexate—colon cancer	0.000108	0.00164	CcSEcCtD
Cisplatin—Hyperhidrosis—Irinotecan—colon cancer	0.000108	0.00163	CcSEcCtD
Cisplatin—ABCC2—lymph node—colon cancer	0.000108	0.00202	CbGeAlD
Cisplatin—Hypotension—Vincristine—colon cancer	0.000107	0.00162	CcSEcCtD
Cisplatin—Bradycardia—Capecitabine—colon cancer	0.000107	0.00162	CcSEcCtD
Cisplatin—Oedema—Fluorouracil—colon cancer	0.000107	0.00162	CcSEcCtD
Cisplatin—Anaphylactic shock—Fluorouracil—colon cancer	0.000107	0.00162	CcSEcCtD
Cisplatin—Anorexia—Irinotecan—colon cancer	0.000106	0.00161	CcSEcCtD
Cisplatin—Infection—Fluorouracil—colon cancer	0.000106	0.00161	CcSEcCtD
Cisplatin—BCHE—liver—colon cancer	0.000106	0.00199	CbGeAlD
Cisplatin—Nervous system disorder—Fluorouracil—colon cancer	0.000105	0.00159	CcSEcCtD
Cisplatin—Thrombocytopenia—Fluorouracil—colon cancer	0.000104	0.00159	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000104	0.00158	CcSEcCtD
Cisplatin—Tachycardia—Fluorouracil—colon cancer	0.000104	0.00158	CcSEcCtD
Cisplatin—Hypotension—Irinotecan—colon cancer	0.000104	0.00158	CcSEcCtD
Cisplatin—Urinary tract disorder—Capecitabine—colon cancer	0.000104	0.00157	CcSEcCtD
Cisplatin—Connective tissue disorder—Capecitabine—colon cancer	0.000103	0.00156	CcSEcCtD
Cisplatin—Urethral disorder—Capecitabine—colon cancer	0.000103	0.00156	CcSEcCtD
Cisplatin—Paraesthesia—Vincristine—colon cancer	0.000103	0.00156	CcSEcCtD
Cisplatin—ABCG2—liver—colon cancer	0.000102	0.00193	CbGeAlD
Cisplatin—Breast disorder—Methotrexate—colon cancer	0.000102	0.00155	CcSEcCtD
Cisplatin—Anorexia—Fluorouracil—colon cancer	0.000102	0.00154	CcSEcCtD
Cisplatin—Visual impairment—Capecitabine—colon cancer	0.000101	0.00153	CcSEcCtD
Cisplatin—PTGS2—bone marrow—colon cancer	0.000101	0.0019	CbGeAlD
Cisplatin—Paraesthesia—Irinotecan—colon cancer	0.0001	0.00152	CcSEcCtD
Cisplatin—Hypotension—Fluorouracil—colon cancer	9.97e-05	0.00151	CcSEcCtD
Cisplatin—Decreased appetite—Vincristine—colon cancer	9.94e-05	0.00151	CcSEcCtD
Cisplatin—Dyspnoea—Irinotecan—colon cancer	9.93e-05	0.00151	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Vincristine—colon cancer	9.88e-05	0.0015	CcSEcCtD
Cisplatin—Eye disorder—Capecitabine—colon cancer	9.81e-05	0.00149	CcSEcCtD
Cisplatin—Tinnitus—Capecitabine—colon cancer	9.78e-05	0.00148	CcSEcCtD
Cisplatin—Pain—Vincristine—colon cancer	9.78e-05	0.00148	CcSEcCtD
Cisplatin—Cardiac disorder—Capecitabine—colon cancer	9.74e-05	0.00148	CcSEcCtD
Cisplatin—Flushing—Capecitabine—colon cancer	9.74e-05	0.00148	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Fluorouracil—colon cancer	9.72e-05	0.00147	CcSEcCtD
Cisplatin—Decreased appetite—Irinotecan—colon cancer	9.68e-05	0.00147	CcSEcCtD
Cisplatin—PTGS2—vagina—colon cancer	9.67e-05	0.00182	CbGeAlD
Cisplatin—Gastrointestinal disorder—Irinotecan—colon cancer	9.62e-05	0.00146	CcSEcCtD
Cisplatin—Paraesthesia—Fluorouracil—colon cancer	9.58e-05	0.00145	CcSEcCtD
Cisplatin—Pancreatitis—Methotrexate—colon cancer	9.57e-05	0.00145	CcSEcCtD
Cisplatin—Pain—Irinotecan—colon cancer	9.53e-05	0.00145	CcSEcCtD
Cisplatin—Dyspnoea—Fluorouracil—colon cancer	9.51e-05	0.00144	CcSEcCtD
Cisplatin—Immune system disorder—Capecitabine—colon cancer	9.48e-05	0.00144	CcSEcCtD
Cisplatin—Mediastinal disorder—Capecitabine—colon cancer	9.46e-05	0.00144	CcSEcCtD
Cisplatin—CYP2B6—liver—colon cancer	9.44e-05	0.00178	CbGeAlD
Cisplatin—Arrhythmia—Capecitabine—colon cancer	9.37e-05	0.00142	CcSEcCtD
Cisplatin—Abdominal discomfort—Methotrexate—colon cancer	9.36e-05	0.00142	CcSEcCtD
Cisplatin—CYP2C9—liver—colon cancer	9.35e-05	0.00176	CbGeAlD
Cisplatin—Decreased appetite—Fluorouracil—colon cancer	9.27e-05	0.00141	CcSEcCtD
Cisplatin—Alopecia—Capecitabine—colon cancer	9.27e-05	0.00141	CcSEcCtD
Cisplatin—Pancytopenia—Methotrexate—colon cancer	9.27e-05	0.00141	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Fluorouracil—colon cancer	9.21e-05	0.0014	CcSEcCtD
Cisplatin—Feeling abnormal—Irinotecan—colon cancer	9.18e-05	0.00139	CcSEcCtD
Cisplatin—Malnutrition—Capecitabine—colon cancer	9.14e-05	0.00139	CcSEcCtD
Cisplatin—Erythema—Capecitabine—colon cancer	9.14e-05	0.00139	CcSEcCtD
Cisplatin—Pain—Fluorouracil—colon cancer	9.12e-05	0.00138	CcSEcCtD
Cisplatin—Body temperature increased—Vincristine—colon cancer	9.04e-05	0.00137	CcSEcCtD
Cisplatin—Flatulence—Capecitabine—colon cancer	9e-05	0.00137	CcSEcCtD
Cisplatin—ABCB1—epithelium—colon cancer	8.9e-05	0.00168	CbGeAlD
Cisplatin—Body temperature increased—Irinotecan—colon cancer	8.81e-05	0.00134	CcSEcCtD
Cisplatin—Feeling abnormal—Fluorouracil—colon cancer	8.79e-05	0.00133	CcSEcCtD
Cisplatin—Muscle spasms—Capecitabine—colon cancer	8.78e-05	0.00133	CcSEcCtD
Cisplatin—Vision blurred—Capecitabine—colon cancer	8.61e-05	0.00131	CcSEcCtD
Cisplatin—Tremor—Capecitabine—colon cancer	8.56e-05	0.0013	CcSEcCtD
Cisplatin—Renal failure—Methotrexate—colon cancer	8.55e-05	0.0013	CcSEcCtD
Cisplatin—Stomatitis—Methotrexate—colon cancer	8.48e-05	0.00129	CcSEcCtD
Cisplatin—Ill-defined disorder—Capecitabine—colon cancer	8.48e-05	0.00129	CcSEcCtD
Cisplatin—Conjunctivitis—Methotrexate—colon cancer	8.46e-05	0.00128	CcSEcCtD
Cisplatin—Anaemia—Capecitabine—colon cancer	8.44e-05	0.00128	CcSEcCtD
Cisplatin—Body temperature increased—Fluorouracil—colon cancer	8.43e-05	0.00128	CcSEcCtD
Cisplatin—Hypersensitivity—Vincristine—colon cancer	8.43e-05	0.00128	CcSEcCtD
Cisplatin—ABCB1—renal system—colon cancer	8.26e-05	0.00155	CbGeAlD
Cisplatin—Malaise—Capecitabine—colon cancer	8.24e-05	0.00125	CcSEcCtD
Cisplatin—Hepatobiliary disease—Methotrexate—colon cancer	8.23e-05	0.00125	CcSEcCtD
Cisplatin—Hypersensitivity—Irinotecan—colon cancer	8.21e-05	0.00125	CcSEcCtD
Cisplatin—Asthenia—Vincristine—colon cancer	8.21e-05	0.00125	CcSEcCtD
Cisplatin—Leukopenia—Capecitabine—colon cancer	8.18e-05	0.00124	CcSEcCtD
Cisplatin—PTGS2—liver—colon cancer	8.16e-05	0.00153	CbGeAlD
Cisplatin—BCHE—lymph node—colon cancer	8.12e-05	0.00153	CbGeAlD
Cisplatin—Asthenia—Irinotecan—colon cancer	7.99e-05	0.00121	CcSEcCtD
Cisplatin—Hypersensitivity—Fluorouracil—colon cancer	7.86e-05	0.00119	CcSEcCtD
Cisplatin—ABCG2—lymph node—colon cancer	7.85e-05	0.00148	CbGeAlD
Cisplatin—Diarrhoea—Vincristine—colon cancer	7.83e-05	0.00119	CcSEcCtD
Cisplatin—Myalgia—Capecitabine—colon cancer	7.78e-05	0.00118	CcSEcCtD
Cisplatin—Anxiety—Capecitabine—colon cancer	7.75e-05	0.00118	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	7.72e-05	0.00117	CcSEcCtD
Cisplatin—Urinary tract disorder—Methotrexate—colon cancer	7.72e-05	0.00117	CcSEcCtD
Cisplatin—Discomfort—Capecitabine—colon cancer	7.68e-05	0.00117	CcSEcCtD
Cisplatin—Urethral disorder—Methotrexate—colon cancer	7.66e-05	0.00116	CcSEcCtD
Cisplatin—Diarrhoea—Irinotecan—colon cancer	7.62e-05	0.00116	CcSEcCtD
Cisplatin—Visual impairment—Methotrexate—colon cancer	7.53e-05	0.00114	CcSEcCtD
Cisplatin—Oedema—Capecitabine—colon cancer	7.46e-05	0.00113	CcSEcCtD
Cisplatin—Infection—Capecitabine—colon cancer	7.41e-05	0.00112	CcSEcCtD
Cisplatin—Nervous system disorder—Capecitabine—colon cancer	7.31e-05	0.00111	CcSEcCtD
Cisplatin—Eye disorder—Methotrexate—colon cancer	7.3e-05	0.00111	CcSEcCtD
Cisplatin—Diarrhoea—Fluorouracil—colon cancer	7.3e-05	0.00111	CcSEcCtD
Cisplatin—Thrombocytopenia—Capecitabine—colon cancer	7.3e-05	0.00111	CcSEcCtD
Cisplatin—Tinnitus—Methotrexate—colon cancer	7.28e-05	0.00111	CcSEcCtD
Cisplatin—Tachycardia—Capecitabine—colon cancer	7.28e-05	0.0011	CcSEcCtD
Cisplatin—Vomiting—Vincristine—colon cancer	7.27e-05	0.0011	CcSEcCtD
Cisplatin—Cardiac disorder—Methotrexate—colon cancer	7.25e-05	0.0011	CcSEcCtD
Cisplatin—Skin disorder—Capecitabine—colon cancer	7.24e-05	0.0011	CcSEcCtD
Cisplatin—Rash—Vincristine—colon cancer	7.21e-05	0.00109	CcSEcCtD
Cisplatin—Hyperhidrosis—Capecitabine—colon cancer	7.21e-05	0.00109	CcSEcCtD
Cisplatin—Dermatitis—Vincristine—colon cancer	7.21e-05	0.00109	CcSEcCtD
Cisplatin—Anorexia—Capecitabine—colon cancer	7.11e-05	0.00108	CcSEcCtD
Cisplatin—Vomiting—Irinotecan—colon cancer	7.08e-05	0.00107	CcSEcCtD
Cisplatin—Immune system disorder—Methotrexate—colon cancer	7.06e-05	0.00107	CcSEcCtD
Cisplatin—Mediastinal disorder—Methotrexate—colon cancer	7.04e-05	0.00107	CcSEcCtD
Cisplatin—Rash—Irinotecan—colon cancer	7.02e-05	0.00107	CcSEcCtD
Cisplatin—Dermatitis—Irinotecan—colon cancer	7.02e-05	0.00106	CcSEcCtD
Cisplatin—Hypotension—Capecitabine—colon cancer	6.97e-05	0.00106	CcSEcCtD
Cisplatin—Alopecia—Methotrexate—colon cancer	6.9e-05	0.00105	CcSEcCtD
Cisplatin—ABCB1—lymphoid tissue—colon cancer	6.86e-05	0.00129	CbGeAlD
Cisplatin—Malnutrition—Methotrexate—colon cancer	6.8e-05	0.00103	CcSEcCtD
Cisplatin—Erythema—Methotrexate—colon cancer	6.8e-05	0.00103	CcSEcCtD
Cisplatin—Nausea—Vincristine—colon cancer	6.79e-05	0.00103	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Capecitabine—colon cancer	6.79e-05	0.00103	CcSEcCtD
Cisplatin—Vomiting—Fluorouracil—colon cancer	6.78e-05	0.00103	CcSEcCtD
Cisplatin—ABCB1—digestive system—colon cancer	6.77e-05	0.00127	CbGeAlD
Cisplatin—Rash—Fluorouracil—colon cancer	6.73e-05	0.00102	CcSEcCtD
Cisplatin—Dermatitis—Fluorouracil—colon cancer	6.72e-05	0.00102	CcSEcCtD
Cisplatin—Paraesthesia—Capecitabine—colon cancer	6.69e-05	0.00102	CcSEcCtD
Cisplatin—Dyspnoea—Capecitabine—colon cancer	6.65e-05	0.00101	CcSEcCtD
Cisplatin—Nausea—Irinotecan—colon cancer	6.62e-05	0.001	CcSEcCtD
Cisplatin—Decreased appetite—Capecitabine—colon cancer	6.48e-05	0.000983	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Capecitabine—colon cancer	6.44e-05	0.000977	CcSEcCtD
Cisplatin—Vision blurred—Methotrexate—colon cancer	6.41e-05	0.000972	CcSEcCtD
Cisplatin—Pain—Capecitabine—colon cancer	6.38e-05	0.000967	CcSEcCtD
Cisplatin—Nausea—Fluorouracil—colon cancer	6.34e-05	0.000962	CcSEcCtD
Cisplatin—Ill-defined disorder—Methotrexate—colon cancer	6.31e-05	0.000957	CcSEcCtD
Cisplatin—Anaemia—Methotrexate—colon cancer	6.29e-05	0.000954	CcSEcCtD
Cisplatin—PTGS2—lymph node—colon cancer	6.26e-05	0.00118	CbGeAlD
Cisplatin—ABCB1—bone marrow—colon cancer	6.25e-05	0.00117	CbGeAlD
Cisplatin—Feeling abnormal—Capecitabine—colon cancer	6.14e-05	0.000932	CcSEcCtD
Cisplatin—Malaise—Methotrexate—colon cancer	6.13e-05	0.000931	CcSEcCtD
Cisplatin—Leukopenia—Methotrexate—colon cancer	6.09e-05	0.000924	CcSEcCtD
Cisplatin—ABCB1—vagina—colon cancer	5.98e-05	0.00113	CbGeAlD
Cisplatin—Body temperature increased—Capecitabine—colon cancer	5.89e-05	0.000894	CcSEcCtD
Cisplatin—Convulsion—Methotrexate—colon cancer	5.89e-05	0.000894	CcSEcCtD
Cisplatin—Myalgia—Methotrexate—colon cancer	5.79e-05	0.000878	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	5.75e-05	0.000872	CcSEcCtD
Cisplatin—Discomfort—Methotrexate—colon cancer	5.72e-05	0.000868	CcSEcCtD
Cisplatin—Anaphylactic shock—Methotrexate—colon cancer	5.55e-05	0.000842	CcSEcCtD
Cisplatin—Infection—Methotrexate—colon cancer	5.51e-05	0.000837	CcSEcCtD
Cisplatin—Hypersensitivity—Capecitabine—colon cancer	5.49e-05	0.000833	CcSEcCtD
Cisplatin—Nervous system disorder—Methotrexate—colon cancer	5.44e-05	0.000826	CcSEcCtD
Cisplatin—Thrombocytopenia—Methotrexate—colon cancer	5.43e-05	0.000825	CcSEcCtD
Cisplatin—Skin disorder—Methotrexate—colon cancer	5.39e-05	0.000818	CcSEcCtD
Cisplatin—Hyperhidrosis—Methotrexate—colon cancer	5.37e-05	0.000814	CcSEcCtD
Cisplatin—Asthenia—Capecitabine—colon cancer	5.35e-05	0.000812	CcSEcCtD
Cisplatin—Anorexia—Methotrexate—colon cancer	5.29e-05	0.000803	CcSEcCtD
Cisplatin—Hypotension—Methotrexate—colon cancer	5.19e-05	0.000787	CcSEcCtD
Cisplatin—Diarrhoea—Capecitabine—colon cancer	5.1e-05	0.000774	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Methotrexate—colon cancer	5.06e-05	0.000767	CcSEcCtD
Cisplatin—ABCB1—liver—colon cancer	5.05e-05	0.000949	CbGeAlD
Cisplatin—Paraesthesia—Methotrexate—colon cancer	4.98e-05	0.000756	CcSEcCtD
Cisplatin—Dyspnoea—Methotrexate—colon cancer	4.95e-05	0.000751	CcSEcCtD
Cisplatin—Decreased appetite—Methotrexate—colon cancer	4.82e-05	0.000732	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Methotrexate—colon cancer	4.79e-05	0.000727	CcSEcCtD
Cisplatin—Pain—Methotrexate—colon cancer	4.75e-05	0.00072	CcSEcCtD
Cisplatin—Vomiting—Capecitabine—colon cancer	4.74e-05	0.000719	CcSEcCtD
Cisplatin—Rash—Capecitabine—colon cancer	4.7e-05	0.000713	CcSEcCtD
Cisplatin—Dermatitis—Capecitabine—colon cancer	4.7e-05	0.000713	CcSEcCtD
Cisplatin—Feeling abnormal—Methotrexate—colon cancer	4.57e-05	0.000694	CcSEcCtD
Cisplatin—Nausea—Capecitabine—colon cancer	4.43e-05	0.000672	CcSEcCtD
Cisplatin—Body temperature increased—Methotrexate—colon cancer	4.39e-05	0.000666	CcSEcCtD
Cisplatin—Hypersensitivity—Methotrexate—colon cancer	4.09e-05	0.00062	CcSEcCtD
Cisplatin—Asthenia—Methotrexate—colon cancer	3.98e-05	0.000604	CcSEcCtD
Cisplatin—ABCB1—lymph node—colon cancer	3.87e-05	0.000728	CbGeAlD
Cisplatin—Diarrhoea—Methotrexate—colon cancer	3.8e-05	0.000576	CcSEcCtD
Cisplatin—Vomiting—Methotrexate—colon cancer	3.53e-05	0.000535	CcSEcCtD
Cisplatin—Rash—Methotrexate—colon cancer	3.5e-05	0.000531	CcSEcCtD
Cisplatin—Dermatitis—Methotrexate—colon cancer	3.5e-05	0.00053	CcSEcCtD
Cisplatin—Nausea—Methotrexate—colon cancer	3.3e-05	0.0005	CcSEcCtD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—BRAF—colon cancer	2.14e-05	0.000564	CbGpPWpGaD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.13e-05	0.000561	CbGpPWpGaD
Cisplatin—PTGS2—Disease—LGR5—colon cancer	2.12e-05	0.000559	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CHST5—colon cancer	2.12e-05	0.000559	CbGpPWpGaD
Cisplatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	2.11e-05	0.000555	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CA7—colon cancer	2.08e-05	0.000548	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—NRAS—colon cancer	2.08e-05	0.000547	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—TP53—colon cancer	1.96e-05	0.000515	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CA7—colon cancer	1.94e-05	0.000512	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—MYC—colon cancer	1.93e-05	0.000509	CbGpPWpGaD
Cisplatin—ABCC3—Transmembrane transport of small molecules—ABCB1—colon cancer	1.91e-05	0.000502	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	1.91e-05	0.000502	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CASP3—colon cancer	1.89e-05	0.000497	CbGpPWpGaD
Cisplatin—ABCC2—NRF2 pathway—TGFB1—colon cancer	1.87e-05	0.000492	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—EP300—colon cancer	1.86e-05	0.00049	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—CASP3—colon cancer	1.84e-05	0.000485	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—BRAF—colon cancer	1.84e-05	0.000484	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—CCND1—colon cancer	1.84e-05	0.000484	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PPARG—colon cancer	1.84e-05	0.000484	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.82e-05	0.00048	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—SRC—colon cancer	1.81e-05	0.000476	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	1.81e-05	0.000476	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—KRAS—colon cancer	1.79e-05	0.00047	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CHST5—colon cancer	1.78e-05	0.000468	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ODC1—colon cancer	1.78e-05	0.000468	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—VEGFA—colon cancer	1.76e-05	0.000464	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	1.76e-05	0.000463	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—NRAS—colon cancer	1.74e-05	0.000458	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ODC1—colon cancer	1.71e-05	0.00045	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CHST5—colon cancer	1.71e-05	0.00045	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—ABCB1—colon cancer	1.7e-05	0.000448	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	1.69e-05	0.000446	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—TYMS—colon cancer	1.67e-05	0.00044	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.64e-05	0.000432	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—BRAF—colon cancer	1.64e-05	0.000432	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CTNNB1—colon cancer	1.64e-05	0.000432	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TGFB1—colon cancer	1.62e-05	0.000426	CbGpPWpGaD
Cisplatin—BCHE—Phospholipid metabolism—PIK3CA—colon cancer	1.6e-05	0.000422	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CDKN1A—colon cancer	1.6e-05	0.000422	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—VEGFA—colon cancer	1.56e-05	0.000412	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AXIN2—colon cancer	1.53e-05	0.000402	CbGpPWpGaD
Cisplatin—MT2A—Immune System—EP300—colon cancer	1.52e-05	0.000401	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—HRAS—colon cancer	1.52e-05	0.0004	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.51e-05	0.000398	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—KRAS—colon cancer	1.5e-05	0.000395	CbGpPWpGaD
Cisplatin—MT2A—Immune System—SRC—colon cancer	1.48e-05	0.00039	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—MYC—colon cancer	1.47e-05	0.000388	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TGFB1—colon cancer	1.47e-05	0.000387	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—ABCB1—colon cancer	1.45e-05	0.000381	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PTGS2—colon cancer	1.44e-05	0.00038	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—EGFR—colon cancer	1.44e-05	0.000379	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.44e-05	0.000378	CbGpPWpGaD
Cisplatin—MT2A—Immune System—NRAS—colon cancer	1.43e-05	0.000375	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—TYMS—colon cancer	1.42e-05	0.000374	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—ABCB1—colon cancer	1.41e-05	0.000371	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.4e-05	0.000368	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—TYMS—colon cancer	1.38e-05	0.000364	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—PIK3CA—colon cancer	1.38e-05	0.000362	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—colon cancer	1.33e-05	0.000351	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.32e-05	0.000346	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.3e-05	0.000343	CbGpPWpGaD
Cisplatin—MT2A—Immune System—EGFR—colon cancer	1.3e-05	0.000342	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.29e-05	0.00034	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	1.29e-05	0.00034	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.28e-05	0.000338	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—HRAS—colon cancer	1.27e-05	0.000335	CbGpPWpGaD
Cisplatin—XDH—Metabolism—ABCB1—colon cancer	1.26e-05	0.000333	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ODC1—colon cancer	1.26e-05	0.000332	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CHST5—colon cancer	1.26e-05	0.000332	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.25e-05	0.000329	CbGpPWpGaD
Cisplatin—XDH—Metabolism—TYMS—colon cancer	1.24e-05	0.000327	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.24e-05	0.000326	CbGpPWpGaD
Cisplatin—MT2A—Immune System—KRAS—colon cancer	1.23e-05	0.000323	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—ABCB1—colon cancer	1.21e-05	0.000319	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—colon cancer	1.21e-05	0.000319	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.21e-05	0.000318	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—EP300—colon cancer	1.2e-05	0.000316	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—TYMS—colon cancer	1.19e-05	0.000313	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PPARG—colon cancer	1.18e-05	0.000312	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CHST5—colon cancer	1.18e-05	0.00031	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ODC1—colon cancer	1.18e-05	0.00031	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.15e-05	0.000304	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.15e-05	0.000303	CbGpPWpGaD
Cisplatin—ABCC5—Disease—FGFR3—colon cancer	1.14e-05	0.000299	CbGpPWpGaD
Cisplatin—MT2A—Immune System—PIK3CA—colon cancer	1.13e-05	0.000297	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—AKT1—colon cancer	1.12e-05	0.000296	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.12e-05	0.000294	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—HRAS—colon cancer	1.1e-05	0.00029	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.1e-05	0.000289	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.09e-05	0.000287	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.07e-05	0.000283	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.07e-05	0.000281	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ABCB1—colon cancer	1.05e-05	0.000277	CbGpPWpGaD
Cisplatin—ABCC5—Disease—APC—colon cancer	1.04e-05	0.000275	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HRAS—colon cancer	1.04e-05	0.000275	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—TYMS—colon cancer	1.03e-05	0.000272	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PPARG—colon cancer	1.01e-05	0.000265	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1e-05	0.000264	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1e-05	0.000263	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—HRAS—colon cancer	9.85e-06	0.000259	CbGpPWpGaD
Cisplatin—ABCC5—Disease—BRAF—colon cancer	9.81e-06	0.000258	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PPARG—colon cancer	9.81e-06	0.000258	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	9.8e-06	0.000258	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	9.8e-06	0.000258	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTGS2—colon cancer	9.31e-06	0.000245	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	9.26e-06	0.000244	CbGpPWpGaD
Cisplatin—MT2A—Immune System—AKT1—colon cancer	9.21e-06	0.000242	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.13e-06	0.00024	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	9.1e-06	0.00024	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ABCB1—colon cancer	8.94e-06	0.000235	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PIK3CA—colon cancer	8.89e-06	0.000234	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	8.86e-06	0.000233	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PPARG—colon cancer	8.8e-06	0.000232	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—TYMS—colon cancer	8.78e-06	0.000231	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	8.77e-06	0.000231	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	8.57e-06	0.000226	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	8.51e-06	0.000224	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—HRAS—colon cancer	8.45e-06	0.000222	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PPARG—colon cancer	8.43e-06	0.000222	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.39e-06	0.000221	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	8.23e-06	0.000217	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	8.15e-06	0.000215	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	7.95e-06	0.000209	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	7.93e-06	0.000209	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTGS2—colon cancer	7.92e-06	0.000209	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTGS2—colon cancer	7.92e-06	0.000208	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—EP300—colon cancer	7.74e-06	0.000204	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	7.72e-06	0.000203	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTGS2—colon cancer	7.71e-06	0.000203	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—HRAS—colon cancer	7.54e-06	0.000199	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.34e-06	0.000193	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PPARG—colon cancer	7.31e-06	0.000192	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—AKT1—colon cancer	7.26e-06	0.000191	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	7.11e-06	0.000187	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CTNNB1—colon cancer	7.09e-06	0.000187	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	7.09e-06	0.000187	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.98e-06	0.000184	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	6.95e-06	0.000183	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	6.95e-06	0.000183	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CDKN1A—colon cancer	6.92e-06	0.000182	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTGS2—colon cancer	6.92e-06	0.000182	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ABCB1—colon cancer	6.83e-06	0.00018	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.76e-06	0.000178	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—TYMS—colon cancer	6.71e-06	0.000177	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTGS2—colon cancer	6.63e-06	0.000175	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EP300—colon cancer	6.59e-06	0.000173	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—EP300—colon cancer	6.58e-06	0.000173	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	6.57e-06	0.000173	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CTNNB1—colon cancer	6.49e-06	0.000171	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—EP300—colon cancer	6.42e-06	0.000169	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SRC—colon cancer	6.41e-06	0.000169	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PPARG—colon cancer	6.22e-06	0.000164	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NRAS—colon cancer	6.16e-06	0.000162	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ABCB1—colon cancer	6.16e-06	0.000162	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ABCB1—colon cancer	6.1e-06	0.000161	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—TYMS—colon cancer	6.05e-06	0.000159	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	6.03e-06	0.000159	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—TYMS—colon cancer	5.99e-06	0.000158	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	5.83e-06	0.000154	CbGpPWpGaD
Cisplatin—XDH—Metabolism—EP300—colon cancer	5.75e-06	0.000152	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTGS2—colon cancer	5.75e-06	0.000151	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MYC—colon cancer	5.74e-06	0.000151	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PIK3CA—colon cancer	5.73e-06	0.000151	CbGpPWpGaD
Cisplatin—ABCC5—Disease—TGFB1—colon cancer	5.73e-06	0.000151	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EGFR—colon cancer	5.62e-06	0.000148	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—EP300—colon cancer	5.52e-06	0.000145	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—colon cancer	5.3e-06	0.00014	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.16e-06	0.000136	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	4.93e-06	0.00013	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—colon cancer	4.89e-06	0.000129	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PIK3CA—colon cancer	4.87e-06	0.000128	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PIK3CA—colon cancer	4.87e-06	0.000128	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.86e-06	0.000128	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.8e-06	0.000126	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—EP300—colon cancer	4.78e-06	0.000126	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PPARG—colon cancer	4.75e-06	0.000125	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CA—colon cancer	4.75e-06	0.000125	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ABCB1—colon cancer	4.7e-06	0.000124	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—AKT1—colon cancer	4.68e-06	0.000123	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—TYMS—colon cancer	4.62e-06	0.000122	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ABCB1—colon cancer	4.52e-06	0.000119	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—colon cancer	4.51e-06	0.000119	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—TYMS—colon cancer	4.44e-06	0.000117	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGFR3—colon cancer	4.41e-06	0.000116	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PPARG—colon cancer	4.29e-06	0.000113	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CA—colon cancer	4.26e-06	0.000112	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PPARG—colon cancer	4.24e-06	0.000112	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CA—colon cancer	4.08e-06	0.000107	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—EP300—colon cancer	4.07e-06	0.000107	CbGpPWpGaD
Cisplatin—PTGS2—Disease—APC—colon cancer	4.04e-06	0.000106	CbGpPWpGaD
Cisplatin—ABCC5—Disease—AKT1—colon cancer	3.98e-06	0.000105	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—AKT1—colon cancer	3.98e-06	0.000105	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—AKT1—colon cancer	3.88e-06	0.000102	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.82e-06	0.000101	CbGpPWpGaD
Cisplatin—PTGS2—Disease—BRAF—colon cancer	3.8e-06	0.0001	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—colon cancer	3.74e-06	9.84e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.55e-06	9.35e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CA—colon cancer	3.54e-06	9.32e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—AKT1—colon cancer	3.48e-06	9.16e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—colon cancer	3.37e-06	8.88e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—colon cancer	3.34e-06	8.79e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—AKT1—colon cancer	3.33e-06	8.78e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—TYMS—colon cancer	3.27e-06	8.61e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PPARG—colon cancer	3.27e-06	8.61e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.18e-06	8.37e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PPARG—colon cancer	3.14e-06	8.27e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ABCB1—colon cancer	3.11e-06	8.19e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—EP300—colon cancer	3.11e-06	8.18e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—TYMS—colon cancer	3.06e-06	8.05e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CA—colon cancer	3.01e-06	7.92e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—AKT1—colon cancer	2.89e-06	7.61e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—EP300—colon cancer	2.8e-06	7.38e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—EP300—colon cancer	2.78e-06	7.31e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CTNNB1—colon cancer	2.75e-06	7.23e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1A—colon cancer	2.68e-06	7.07e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EP300—colon cancer	2.55e-06	6.72e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SRC—colon cancer	2.48e-06	6.54e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—colon cancer	2.47e-06	6.51e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AKT1—colon cancer	2.46e-06	6.47e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NRAS—colon cancer	2.39e-06	6.29e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.35e-06	6.19e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PPARG—colon cancer	2.32e-06	6.1e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CA—colon cancer	2.3e-06	6.05e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MYC—colon cancer	2.23e-06	5.86e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TGFB1—colon cancer	2.22e-06	5.85e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EGFR—colon cancer	2.18e-06	5.73e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PPARG—colon cancer	2.17e-06	5.7e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—EP300—colon cancer	2.14e-06	5.63e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CA—colon cancer	2.07e-06	5.46e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—colon cancer	2.06e-06	5.41e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—EP300—colon cancer	2.06e-06	5.41e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CA—colon cancer	2.05e-06	5.41e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CA—colon cancer	1.89e-06	4.97e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKT1—colon cancer	1.88e-06	4.94e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—colon cancer	1.82e-06	4.8e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—colon cancer	1.75e-06	4.6e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—colon cancer	1.7e-06	4.48e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKT1—colon cancer	1.69e-06	4.46e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKT1—colon cancer	1.68e-06	4.42e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CA—colon cancer	1.58e-06	4.17e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT1—colon cancer	1.54e-06	4.06e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CA—colon cancer	1.52e-06	4e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—EP300—colon cancer	1.52e-06	3.99e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—EP300—colon cancer	1.42e-06	3.73e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKT1—colon cancer	1.29e-06	3.4e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKT1—colon cancer	1.24e-06	3.27e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CA—colon cancer	1.12e-06	2.95e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CA—colon cancer	1.05e-06	2.76e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKT1—colon cancer	9.16e-07	2.41e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKT1—colon cancer	8.56e-07	2.25e-05	CbGpPWpGaD
